Atlas Trials

A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Trial

Clinical trial NCT03642691 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT03642691
Sponsor
Prometic Biotherapeutics, Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Hypoplasminogenemia

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.